Showing 1 - 4 of 4
Persistent link: https://www.econbiz.de/10010848781
<Emphasis Type="Bold">Background: About 7% of children and adolescents are diagnosed with attention-deficit/hyperactivity disorder (ADHD) in the US. Patients with ADHD who are intolerant of or do not have an optimal response to stimulants often use non-stimulants as alternative therapies. Guanfacine extendedrelease...</emphasis>
Persistent link: https://www.econbiz.de/10011000747
Persistent link: https://www.econbiz.de/10011000750
The impairment associated with residual ADHD symptoms after stimulant therapy is becoming increasingly recognized. This is the first analysis of the cost effectiveness of stimulants combined with an adjunctive medication. This study suggests that the adjunctive therapy of GXR with stimulants is...
Persistent link: https://www.econbiz.de/10011001572